Y peginterferon alfa-2b

DRUG2 trials

Sponsors

Tongji Hospital, Qin Ning

Conditions

Chronic Hepatitis bHepatitis B, Chronic

Phase 3

A Prospective Clinical Trial in Chronic Hepatitis B Patients NAs (Nucleotides or Nucleosides) Experienced (Anchor Study)

Tongji HospitalHepatitis B, Chronic

Start: 2014-10-31End: 2019-06-30Target: 300Updated: 2016-08-15

Phase 4

Sequential/Combination Therapy in Nucleoside or Nucleotide Analogue (NA)-Suppressed Chronic Hepatitis B Patients

Qin NingChronic Hepatitis b

Start: 2015-12-01End: 2019-12-31Updated: 2017-11-06

Related Papers

Efficacy and safety of entecavir, peginterferon alfa-2b and GM-CSF combination therapy: the anchor randomized controlled trial.

2025-12-091 citations

High‐Throughput Viral Integration Detection Reveals Baseline Breakpoints Burden Associated With <scp>HBsAg</scp> Seroclearance

Alimentary Pharmacology & Therapeutics2025-07-162 citations

End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB

Journal of Hepatology2022-02-0892 citations